Generally, each drug made up of two components that are API and excipients, having curative activity. APIs are often known as bulk pharmaceuticals and most of all APIs are in powder form. Active Pharmaceutical Ingredients (APIs) are active substances in a drug intended to achieve pharmacological activity which is having a direct effect on disease treatment. APIs are synthesized based on chemical synthesis, fermentation, biotechnological methods or enhanced from the natural source.
The API global market is expected to grow at a high single digit CAGR from 2022 to 2029 to reach $388,002.4 million by 2029. The major factors driving the API market are increasing incidence and prevalence of various chronic diseases, adoption of biologics in disease management & increasing regulatory approvals and increasing R&D expenditure & expansion of manufacturing facilities. Whereas, growing scope for HPAPI and next generation therapeutics such as cell therapy and gene therapy, increasing patent expiration and trend of outsourcing are providing immense opportunity to the API market. The high risk of contamination during the manufacturing of API, high cost for manufacturing of complex and advanced API’s, presence of alternatives and stringent regulations associated with pharma manufacturing are hindering the market growth.
The global API market is mainly segmented based on synthesis, business type, application, and geography. Based on synthesis, the API global market is segmented into synthetic API, biotech API and HPAPI. Among these, synthetic API accounted for the highest revenue in 2022 and is expected to grow at a mid single digit CAGR from 2022 to 2029. Biotech API is expected to grow at a double digit CAGR from 2022 to 2029. Based on product type, Biotech API is further segmented into antibodies, recombinant proteins, vaccines, cell therapy, gene therapy and others. Among these, antibodies segment accounted for the highest revenue in 2022 and is expected to grow at a double digit CAGR from 2022 to 2029. Gene Therapy is expected to grow at a mid teen CAGR from 2022 to 2029. Antibodies global market is further classified into monoclonal antibody, bispecific and others. Among these, Monoclonal Antibody segment is accounted for the highest revenue in 2022 and is expected to grow at a double digit CAGR from 2022 to 2029. Bispecific segment is expected to grow at an early teen CAGR from 2022 to 2029. Based on the customer base, the global biotech API is further segmented into biologics and biosimilars. Biologics accounted for the highest revenue in 2022 and is expected to grow at a high single digit CAGR from 2022 to 2029. Biosimilar API segment is expected to grow at a mid teen CAGR from 2022 to 2029.
Synthetic API global market based on customer base is further segmented into branded and generic synthetic API. Among these, branded synthetic AP global market accounted for the highest revenue in 2022 and is expected to grow at a mid single digit CAGR from 2022 to 2029. Generic synthetic API market is expected to grow at a high single digit CAGR from 2022 to 2029.
The HPAPI global market is estimated to be $XX million in 2022 and is expected to grow at a double digit CAGR from 2022 to 2029. The global HPAPI market based on customer base is further classified into branded and generic HPAPI. Among these, branded HPAPI accounted for the highest revenue in 2022 and is expected to grow at a high single digit CAGR from 2022 to 2029. Generic HPAPI is expected to grow at an early teen CAGR of 11.8% from 2022 to 2029.
Based on business type, the API global market is segmented into Captive and Merchant API. Among these, captive API accounted for the highest revenue in 2022 and is expected to grow at a mid single digit CAGR from 2022 to 2029. Merchant API segment is expected to grow at high single digit CAGR from 2022 to 2029. The Captive API global market is further segmented into branded and generic API. Among these, branded API accounted for the highest revenue in 2022 and is expected to grow at a mid single digit CAGR from 2022 to 2029. The merchant API global market is further segmented into branded and generic API. Among these, branded merchant API accounted for the highest revenue in 2022 and is expected to grow at a high single digit CAGR from 2022 to 2029. Generic Merchant API segment is expected to grow at early teen CAGR from 2022 to 2029.
The API global market based on application is segmented into infectious diseases, oncology, cardiovascular diseases, central nervous system, pulmonary diseases, gastrointestinal diseases, endocrine diseases, metabolic disorders, genito-urinary diseases, musculoskeletal diseases and others such as ophthalmology, nephrology, hepatology, ENT, dental, dermatology, and pain management. Among the application, the infectious disease segment accounted for the highest revenue in 2022 and is expected to grow at a mid single digit CAGR from 2022 to 2029. Oncology is expected to grow at a double digit CAGR from 2022 to 2029.
In synthetic API global market based on application, infectious disease segment accounted for the highest revenue in 2022 and is expected to grow at a mid single digit CAGR from 2022 to 2029. Oncology is expected to grow at a high single digit CAGR from 2022 to 2029. In Biotech API global market based on application, musculoskeletal diseases segment accounted for the largest revenue in 2022 and is expected to grow at a double digit CAGR from 2022 to 2029. The oncology segment is expected to grow at a strong early teen CAGR from 2022 to 2029. The HPAPI global market based on application, the oncology segment accounted for the largest revenue in 2022 and is expected to grow at a early teen CAGR from 2022 to 2029.
The active pharmaceutical Ingredients global market based on region is segmented as North America, Europe, Asia-Pacific, and the Rest of the world (ROW). Among the region, North America accounted for the highest revenue in 2022 and is expected to grow at a mid single digit CAGR from 2022 to 2029. Growing pharma R&D expenditure, increasing development of new drugs over the time, increasing approval of generics and biosimilars, growing biopharmaceutical drugs pipelines, presence of number of API manufacturing facilities for all regulated drug products, increasing scope of highly potent drugs, government support to expand the domestic pharmaceutical manufacturing facilities and increase in the prevalence of infectious diseases, cancer, central nervous system associated diseases, cardiac disease, and musculoskeletal disorder are some of the major diseases that are driving the market growth. Asia-Pacific is the fastest-growing region with a high single digit CAGR from 2022 to 2029. The factors such as increasing generic pharmaceuticals and vaccines production, number of pharma companies with a strong network of manufacturing facilities, increasing outsourcing with number of CMO’s and expanding manufacturing facilities, increasing development of new pharma and biopharma drugs, growing biotech R&D investment, presence of number of innovative biotech startups, presence of dedicated departments to support biotechnology research, increasing government investment to support the pharma and biotech industry, low labor cost, and increased prevalence of infectious and other chronic diseases are driving the market growth.
Some of the key players of Active pharmaceutical Ingredient (API) market are Catalent Inc (U.S.), Divis Laboratories (India), Lonza Group (Switzerland), Samsung Biologics, (South Korea), Wuxi Biologics (China), Wuxi Apptec (China), Pfizer Inc. (U.S.), EuroAPI (France), Thermo Fisher Scientific (Patheon N.V.) (U.S.) and Teva Pharmaceutical Industries Limited (Israel).
The report provides an in-depth market analysis of the above-mentioned segments across the following regions:
- North America
- U.S.
- Rest of North America
- Europe
- Italy
- Germany
- France
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Rest of APAC
- Rest of the World (RoW)
- Brazil
- Rest of Latin America
- Middle East and Others
Table of Contents
1 Executive Summary
2 Introduction
2.1 Key Takeaways
2.2 Scope of the Report
2.3 Report Description
2.4 Markets Covered
2.5 Stakeholders
2.6 Research Methodology
2.6.1 Market Size Estimation
2.6.2 Market Breakdown and Data Triangulation
2.6.3 Secondary Sources
2.6.4 Primary Sources
2.6.5 Key Data Points from Secondary Sources
2.6.6 Key Data Points from Primary Sources
2.6.7 Assumptions
3 Market Analysis
3.1 Introduction
3.2 Market Segmentation
3.3 Factors Influencing Market
3.3.1 Drivers and Opportunities
3.3.1.1 Increasing Incidence and Prevalence of Chronic, Communicable and Autoimmune Diseases
3.3.1.2 Adoption of Biologics in Disease Management and Increasing Regulatory Approvals
3.3.1.3 Increasing Investment in Research and Development (R&D) and Expansion of Manufacturing Facilities
3.3.1.4 Patent Expiration of Major Drugs
3.3.1.5 Increasing Scope of Hpapi and Advanced Next Generation Biologics Market
3.3.1.6 Increasing Trend of Outsourcing and Adoption in Emerging Market
3.3.1.7 Increase in the Geriatric Population
3.3.2 Restraints and Threats
3.3.2.1 Contamination of API
3.3.2.2 High Cost for Manufacturing Apis
3.3.2.3 a Requirement of Highly Skilled Technicians
3.3.2.4 Pierce Competition Between API Players
3.3.2.5 Presence of Alternatives
3.3.2.6 Stringent Regulatory Policies and Environmental Concerns
3.4 Regulatory Affairs
3.4.1 International Organization for Standardization
3.4.1.1 Iso 9001: 2015 Quality Management System
3.4.1.2 Iso 13408 Aseptic Processing
3.4.1.3 Iso 14644-1 Clean Room Standards
3.4.2 U.S.
3.4.3 Canada
3.4.4 Mexico
3.4.5 Europe
3.4.6 China
3.4.7 India
3.4.8 Japan
3.4.9 Australia
3.4.10 South Korea
3.4.11 Latin America
3.4.12 Middle East
3.5 Technological Advancements
3.5.1 Introduction
3.5.2 Automation and Control
3.5.3 Continuous Flow Manufacturing
3.5.4 Cryogenic Technology
3.5.5 Single - Use System (Sus)
3.5.6 Artificial Intelligence in API Manufacturing
3.5.7 Chemistry in Water
3.5.8 M-Rna Technology in Vaccine Manufacturing
3.5.9 Advancements in Hpapi Manufacturing
3.6 Porter's Five Force Analysis
3.6.1 Threat of New Entrants
3.6.2 Threat of Substitutes
3.6.3 Bargaining Power of Suppliers
3.6.4 Bargaining Power of Buyers
3.6.5 Competitive Rivalry
3.7 Supply Chain Analysis
3.8 Market Share Analysis
3.8.1 Market Share Analysis of Merchant API Global Market
3.8.2 Market Share Analysis of Merchant Synthetic API Global Market
3.8.3 Market Share Analysis of Merchant Biotech API Global Market
3.9 Fda Approved API Manufacturing Units
3.10 Pharmaceutical API Production Volume
3.11 Patent Expiry and Anda Approvals
3.12 Drug Master Filing (Dmf)
3.13 Repurposed Drugs for COVID-19 Treatment
3.14 Acquisition, Merger, and Expansions in API Manufacturing
3.15 Selected Top Selling API
3.16 API Manufacturers Revenue and Capabilities Table
4 API Global Market, Based on Synthesis
4.1 Introduction
4.2 Synthetic API
4.2.1 Synthetic API Based on Customer Base
4.2.1.1 Branded Synthetic API
4.2.1.2 Generic Synthetic API
4.3 Biotech API
4.3.1 Antibodies
4.3.1.1 Monoclonal Antibody
4.3.1.2 Bispecific Antibody
4.3.1.3 Others (Polyclonal Antibody, Antibody Fragments)
4.3.2 Recombinant Proteins
4.3.3 Vaccines
4.3.4 Gene Therapy
4.3.5 Cell Therapy
4.3.6 Other Biotech API
4.3.7 Biotech API Based on Customer Base
4.3.7.1 Biologic API
4.3.7.2 Biosimilar API
4.4 Hpapi
4.4.1 Hpapi Based on Customer Base
4.4.1.1 Branded Hpapi
4.4.1.2 Generic Hpapi
5 API Global Market, Based on Business Type
5.1 Introduction
5.2 Captive API Based on Type
5.2.1 Branded Captive API
5.2.2 Generic Captive API
5.3 Merchant API Based on Type
5.3.1 Branded Merchant API
5.3.2 Generic Merchant API
6 API Global Market, Based on Application
6.1 Introduction
6.2 Infectious Diseases
6.3 Oncology
6.4 Cardiovascular Diseases
6.5 Central Nervous System
6.6 Pulmonary Diseases
6.7 Gastrointestinal Diseases
6.8 Endocrine Diseases
6.9 Metabolic Disorders
6.10 Genitourinary Diseases
6.11 Musculoskeletal Diseases
6.12 Other Applications (Nephrology, Hepatology, Opthalmology, Dental, Pain Management, Dermatology,Ent Etc.,)
7 Regional Analysis
7.1 Introduction
7.2 North America
7.2.1 U.S.
7.2.2 Rest of North America
7.3 Europe
7.3.1 Italy
7.3.2 Germany
7.3.3 France
7.3.4 Rest of Europe
7.4 APAC
7.4.1 China
7.4.2 Japan
7.4.3 India
7.4.4 Rest of APAC
7.5 RoW
7.5.1 Brazil
7.5.2 Rest of Latam
7.5.3 Middle East & Others
8 Competitive Landscape
8.1 Introduction
8.2 Collaboration, Partnership and Agreement
8.3 Expansion
8.4 Approvals
8.5 New Product, Service and Technology Launch
8.6 Acquisition
8.7 Others
9 Major Companies
9.1 Catalent Inc.
9.1.1 Overview
9.1.2 Financials
9.1.3 Service Portfolio
9.1.4 Key Developments
9.1.5 Business Strategy
9.1.6 SWOT Analysis
9.2 Divis Laboratories
9.2.1 Overview
9.2.2 Financials
9.2.3 Product Portfolio
9.2.4 Key Developments
9.2.5 Business Strategy
9.2.6 SWOT Analysis
9.3 Euroapi
9.3.1 Overview
9.3.2 Financials
9.3.3 Product Portfolio
9.3.4 Key Developments
9.3.5 Business Strategy
9.3.6 SWOT Analysis
9.4 Lonza Group Ltd.
9.4.1 Overview
9.4.2 Financials
9.4.3 Services Portfolio
9.4.4 Key Developments
9.4.5 Business Strategy
9.4.6 SWOT Analysis
9.5 Pfizer Inc.
9.5.1 Overview
9.5.2 Financials
9.5.3 Sevice Portfolio
9.5.4 Key Developments
9.5.5 Business Strategy
9.5.6 SWOT Analysis
9.6 Samsung Biologics Co. Ltd.
9.6.1 Overview
9.6.2 Financials
9.6.3 Service Portfolio
9.6.4 Key Developments
9.6.5 Business Strategy
9.6.6 SWOT Analysis
9.7 Teva Pharmaceutical Industries Limited.
9.7.1 Overview
9.7.2 Financials
9.7.3 Product Portfolio
9.7.4 Key Developments
9.7.5 Business Strategy
9.7.6 SWOT Analysis
9.8 Thermo Fisher Scientific Inc
9.8.1 Overview
9.8.2 Financials
9.8.3 Service Portfolio
9.8.4 Key Developments
9.8.5 Business Strategy
9.8.6 SWOT Analysis
9.9 Wuxi Apptec Co. Ltd.
9.9.1 Overview
9.9.2 Financials
9.9.3 Service Portfolio
9.9.4 Key Developments
9.9.5 Business Strategy
9.9.6 SWOT Analysis
9.10 Wuxi Biologics (Cayman) Inc.
9.10.1 Overview
9.10.2 Financials
9.10.3 Service Portfolio
9.10.4 Key Developments
9.10.5 Business Strategy
9.10.6 SWOT Analysis
List of Tables
Table 1 API Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 2 Global Small Molecule API Revenue ($Mn), Average Selling Price ($/Kg) and Production in Tons Based on Application (2022)
Table 3 Global Small Molecule Volume and Utilization, Cmo Volume and Utilization, (2021-2029) (Million Litres)
Table 4 Global Small Molecule API Production, Based on Application, (2021-2029) (Tons)
Table 5 Global Biologics Volume and Utilization, Cmo Volume and Utilization, (2021-2029) (Million Litres)
Table 6 Global Small Molecule API Production, (2021-2029) (Metric Tons)
Table 7 Global Biologics API Production, (2021-2029) (Metric Tons)
Table 8 Global API Production, (2021-2029) (Metric Tons)
Table 9 Patent Expiry of Synthetic API Drugs, (2022 - 2024)
Table 10 Patent Expiry of Biotech API Drugs, (2018 - 2030)
Table 11 Anda Approvals: Small Molecules - Generics, (2020 - 2022)
Table 12 Fda Approved Biosimilars, (2021 - 2022)
Table 13 Expansion (2021- 2022)
Table 14 Companies Acquisition and Merger, (2021 - 2022)
Table 15 API Global Market Revenue, Based on Synthesis, (2021-2029) ($Mn)
Table 16 Synthetic API Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 17 Synthetic API Global Market Revenue, Based on Customer Base, (2021-2029) ($Mn)
Table 18 Branded Synthetic API Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 19 Generic Synthetic API Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 20 Biotech API Global Market Revenue, Based on Product Type, (2022-2029) ($Mn)
Table 21 Biotech API Global Market Revenue, by Region, (2021-2029) ($Mn)
Table 22 Fda Approved Biologics (2019-2021)
Table 23 Antibody Global Market Revenue, Based on Product Type (2021-2029) ($Mn)
Table 24 Antibody Global Market Revenue, Based on Region (2021-2029) ($Mn)
Table 25 Monoclonal Antibodies Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 26 Bi-Specific Antibodies Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 27 Others Global Market Revenue, Based on Region, (2022-2029) ($Mn)
Table 28 Recombinant Proteins Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 29 Vaccines Global Market Revenue, Based on Region, (2022-2029) ($Mn)
Table 30 Gene Therapy Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 31 Cell Therapy Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 32 Other Biotech API Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 33 Biotech API Global Market Revenue, Based on Customer Base, (2021-2029) ($Mn)
Table 34 Biologic API Global Market Revenue, Based on Region, (2022-2029) ($Mn)
Table 35 Biosimilar API Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 36 Hpapi Global Market Revenue, by Region, (2021-2029) ($Mn)
Table 37 Hpapi Global Market Revenue, Based on Customer Base, (2021-2029) ($Mn)
Table 38 Branded Hpapi Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 39 Generic Hpapi Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 40 API Global Market Revenue, Based on Business Type, (2021-2029) ($Mn)
Table 41 Captive API Global Market Revenue, Based on Type, (2021-2029) ($Mn)
Table 42 Captive API Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 43 Branded Captive API Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 44 Generic Captive API Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 45 Merchant API Global Market Revenue, Based on Type, (2021-2029) ($Mn)
Table 46 Merchant API Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 47 Branded Merchant API Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 48 Generic Merchant API Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 49 API Global Market Revenue, Based on Application, (2021-2029) ($Mn)
Table 50 Synthetic API Global Market Revenue, Based on Application, (2021-2029) ($Mn)
Table 51 Biotech API Global Market Revenue, Based on Application, (2021-2029) ($Mn)
Table 52 Hpapi Global Market Revenue, Based on Application, (2021-2029) ($Mn)
Table 53 Infectious Diseases API Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 54 Synthetic Infectious Diseases API Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 55 Biotech Infectious Diseases API Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 56 Hpapi Infectious Diseases Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 57 Oncology API Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 58 Synthetic Oncology API Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 59 Biotech Oncology API Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 60 Hpapi Oncology Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 61 Cardiovascular Diseases API Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 62 Synthetic Cardiovascular Diseases API Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 63 Biotech Cardiovascular Diseases API Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 64 Hpapi Cardiovascular Diseases Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 65 Central Nervous System API Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 66 Synthetic Central Nervous System API Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 67 Biotech Central Nervous System API Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 68 Hpapi Central Nervous System Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 69 Pulmonary Diseases API Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 70 Synthetic Pulmonary Diseases API Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 71 Biotech Pulmonary Diseases API Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 72 Hpapi Pulmonary Diseases Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 73 Gastrointestinal Diseases API Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 74 Synthetic Gastrointestinal Diseases API Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 75 Biotech Gastrointestinal Diseases API Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 76 Hpapi Gastrointestinal Diseases Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 77 Endocrine Diseases API Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 78 Synthetic Endocrine Diseases API Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 79 Biotech Endocrine Diseases API Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 80 Hpapi Endocrine Diseases Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 81 Metabolic Disorders API Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 82 Synthetic Metabolic Disorders API Global Market Revenue, by Region, (2021-2029) ($Mn)
Table 83 Biotech Metabolic Disorders API Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 84 Hpapi Metabolic Disorders Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 85 Genitourinary Diseases API Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 86 Synthetic Genitourinary Diseases API Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 87 Biotech Genitourinary Diseases API Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 88 Hpapi Genitourinary Diseases Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 89 Musculoskeletal Diseases API Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 90 Synthetic Musculoskeletal Diseases API Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 91 Biotech Musculoskeletal Diseases API Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 92 Hpapi Musculoskeletal Diseases Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 93 Other Applications API Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 94 Synthetic Other Applications API Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 95 Biotech Other Applications API Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 96 Hpapi Other Applications Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 97 API Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 98 North America API Market Revenue, Based on Synthesis, (2021-2029) ($Mn)
Table 99 North America Biotech API Market Revenue, Based on Product Type, (2021-2029) ($Mn)
Table 100 North America Antibodies Market Revenue, Based on Product Type, (2021-2029) ($Mn)
Table 101 North America Synthetic API Market Revenue, Based on Customer Base, (2021-2029) ($Mn)
Table 102 North America Biotech API Market Revenue, Based on Customer Base, (2021-2029) ($Mn)
Table 103 North America Hpapi Market Revenue, Based on Customer Base, (2021-2029) ($Mn)
Table 104 North America API Market Revenue, Based on Business Type, (2021-2029) ($Mn)
Table 105 North America Captive API Market Revenue, Based on Type, (2021-2029) ($Mn)
Table 106 North America Merchant API Market Revenue, Based on Type, (2021-2029) ($Mn)
Table 107 North America API Market Revenue, Based on Application, (2021-2029) ($Mn)
Table 108 North America Synthetic API Market Revenue, Based on Application, (2021-2029) ($Mn)
Table 109 North America Biotech API Market Revenue, Based on Application, (2021-2029) ($Mn)
Table 110 North America Hpapi Market Revenue, Based on Application, (2021-2029) ($Mn)
Table 111 North America API Market Revenue, Based on Country, (2021-2029) ($Mn)
Table 112 Europe API Market Revenue, Based on Synthesis, (2021-2029) ($Mn)
Table 113 Europe Biotech API Market Revenue, Based on Product Type, (2021-2029) ($Mn)
Table 114 Europe Antibodies Market Revenue, Based on Product Type, (2021-2029) ($Mn)
Table 115 Europe Synthetic API Market Revenue, Based on Customer Base, (2021-2029) ($Mn)
Table 116 Europe Biotech API Market Revenue, Based on Customer Base, (2021-2029) ($Mn)
Table 117 Europe Hpapi Market Revenue, Based on Customer Base, (2021-2029) ($Mn)
Table 118 Europe API Market Revenue, Based on Business Type, (2021-2029) ($Mn)
Table 119 Europe Captive API Market Revenue, Based on Type, (2021-2029) ($Mn)
Table 120 Europe Merchant API Market Revenue, Based on Type, (2021-2029) ($Mn)
Table 121 Europe API Market Revenue, Based on Application, (2021-2029) ($Mn)
Table 122 Europe Synthetic API Market Revenue, Based on Application, (2021-2029) ($Mn)
Table 123 Europe Biotech API Market Revenue, Based on Application, (2021-2029) ($Mn)
Table 124 Europe Hpapi Market Revenue, by Application, (2021-2029) ($Mn)
Table 125 Europe API Market Revenue, by Country, (2021-2029) ($Mn)
Table 126 APAC API Market Revenue, Based on Synthesis, (2021-2029) ($Mn)
Table 127 APAC Biotech API Market Revenue, Based on Product Type, (2021-2029) ($Mn)
Table 128 APAC Antibodies Market Revenue, Based on Product Type, (2021-2029) ($Mn)
Table 129 APAC Synthetic API Market Revenue, Based on Customer Base, (2021-2029) ($Mn)
Table 130 APAC Biotech API Market Revenue, Based on Customer Base, (2021-2029) ($Mn)
Table 131 APAC Hpapi Market Revenue, Based on Customer Base, (2021-2029) ($Mn)
Table 132 APAC API Market Revenue, Based on Business Type, (2021-2029) ($Mn)
Table 133 APAC Captive API Market Revenue, Based on Type, (2021-2029) ($Mn)
Table 134 APAC Merchant API Market Revenue, Based on Type, (2021-2029) ($Mn)
Table 135 APAC API Market Revenue, Based on Application, (2021-2029) ($Mn)
Table 136 APAC Synthetic API Market Revenue, Based on Application, (2021-2029) ($Mn)
Table 137 APAC Biotech API Market Revenue, by Application, (2021-2029) ($Mn)
Table 138 APAC Hpapi Market Revenue, Based on Application, (2021-2029) ($Mn)
Table 139 APAC API Market Revenue, Based on Country, (2021-2029) ($Mn)
Table 140 RoW API Market Revenue, Based on Synthesis, (2021-2029) ($Mn)
Table 141 RoW Biotech API Market Revenue, Based on Product Type, (2022-2029) ($Mn)
Table 142 RoW Antibodies Market Revenue, Based on Product Type, (2021-2029) ($Mn)
Table 143 RoW Synthetic API Market Revenue, Based on Customer Base, (2021-2029) ($Mn)
Table 144 RoW Biotech API Market Revenue, Based on Customer Base, (2021-2029) ($Mn)
Table 145 RoW Hpapi Market Revenue, Based on Customer Base, (2021-2029) ($Mn)
Table 146 RoW API Market Revenue, Based on Business Type, (2021-2029) ($Mn)
Table 147 RoW Captive API Market Revenue, Based on Type, (2021-2029) ($Mn)
Table 148 RoW Merchant API Market Revenue, Based on Type, (2021-2029) ($Mn)
Table 149 RoW API Market Revenue, Based on Application, (2021-2029) ($Mn)
Table 150 RoW Synthetic API Market Revenue, Based on Application, (2021-2029) ($Mn)
Table 151 RoW Biotech API Market Revenue, Based on Application, (2021-2029) ($Mn)
Table 152 RoW Hpapi Market Revenue, by Application, (2021-2029) ($Mn)
Table 153 RoW API Market Revenue, Based on Country, (2022-2029) ($Mn)
Table 154 Collaboration, Partnership and Agreement
Table 155 Expansion
Table 156 Approvals
Table 157 New Product, Service and Technology Launch
Table 158 Acquisition
Table 159 Others
Table 160 Catalent Inc: Total Revenue and R&D Expenses (2021-2023) (Q1) ($Mn)
Table 161 Catalent Inc: Total Revenue, by Segment, (2021-2023) (Q1) ($Mn)
Table 162 Catalent Inc: Total Revenue, by Geogrpahy, (2021-2023) (Q1) ($Mn)
Table 163 Divis Laboratories Ltd: Total Revenue and R&D Expenses (2020-2022) (Q2) ($Mn)
Table 164 Divis Laboratories Ltd: Total Revenue, by Geography (2020-2022) (Q2) ($Mn)
Table 165 Euroapi: Total Revenue and R&D Expenses, (2020 - 2022) (Q2) ($Mn)
Table 166 Euroapi: Total Revenue, by Segments, (2020-2022) (Q2) ($Mn)
Table 167 Lonza Group: Total Revenue & R&D Expenses (2020 -2022) (Q2) ($Mn)
Table 168 Lonza Group: Total Revenue, by Segment, (2020 -2022) (Q2) ($Mn)
Table 169 Lonza Group: Total Revenue, by Geography (2020 -2022) (Q2) ($Mn)
Table 170 Pfizer Inc: Total Revenue and R&D Expenses, (2020-2022) (Q3) ($Mn)
Table 171 Pfizer Inc: Total Revenue, by Segments, (2020-2022) (Q3) ($Mn)
Table 172 Pfizer Inc: Total Revenue, by Geography, (2020-2022) (Q3) ($Mn)
Table 173 Samsung Biologics Co: Total Revenue (2020-2022) (Q3) ($Mn)
Table 174 Teva Pharmaceutical Industries Limited: Total Revenue and R&D Expenses (2020-2022) (Q3) ($Mn)
Table 175 Teva Pharmaceutical Industries Limited: Total Revenue by Segment (2020-2022) (Q3) ($Mn)
Table 176 Teva Pharmaceutical Industries Limited: Total Revenue by Geography (2020-2022) (Q3) ($Mn)
Table 177 Thermo Fisher Scientific Inc.: Total Revenue and R&D Expenses (2020-2022) (Q3) ($Mn)
Table 178 Thermo Fisher Scientific Inc.: Total Revenue, by Segment, (2020-2022) (Q3) ($Mn)
Table 179 Thermo Fisher Scientific Inc.: Total Revenue, by Geography (2020-2022)(Q3) ($Mn)
Table 180 Wuxi Apptec Co. Ltd.: Total Revenue and R&D Expenses, (2020-2022) (Q3) ($Mn)
Table 181 Wuxi Apptec Co. Ltd.: Total Revenue, by Segments, (2020-2022) (Q3) ($Mn)
Table 182 Wuxi Biologics: Total Revenue and R&D Expenses, (2020-2022) (Q2)($Mn)
Table 183 Wuxi Biologics: Total Revenue, by Segments, (2020-2022) (Q2) ($Mn)
Table 184 Wuxi Biologics: Total Revenue, by Geography, (2020-2022) (Q2) ($Mn)
List of Figures
Figure 1 API Global Market Revenue, Based on Region (2021-2029) ($Mn)
Figure 2 Research Methodology: API Global Market
Figure 3 API Global Market: Top-Down and Bottom-Up Approach
Figure 4 API Global Market: Forecasting Model
Figure 5 API Global Market: Market Breakdown and Data Triangulation
Figure 6 API Global Market Segmentation
Figure 7 Market Dynamics
Figure 8 API Global Market: Porter's Analysis
Figure 9 API Global Market: Supply Chain Analysis
Figure 10 Merchant API Global Market Share Analysis, by Major Players, 2022 (%)
Figure 11 Merchant Synthetic API Global Market Share Analysis, by Major Players, 2022 (%)
Figure 12 Merchant Biotach API Global Market Share Analysis, by Major Players, 2022 (%)
Figure 13 Fda Approved Global API Manufacturing Landscape
Figure 14 Small Molecule API Production Based on Application (2022), In-House V/S Cmo (2021 - 2029) (Tons) and Global Manufacturing Capacities (2022) (Litres)
Figure 15 Global Total API and Cmo Production (2021 - 2029) (Metric Tons)
Figure 16 Patent Expiry of Small Molecules (2022-2024)
Figure 17 Patent Expiry of Synthetic API Drugs, Based on Application Share (2022-2024) (%)
Figure 18 Anda Approvals of Synthetic API Drugs, Based on Application Share (2020-2022) (%)
Figure 19 API Dmf Filed Based on Region and Countries (No's) (2021)
Figure 20 API Dmf Filed, Based on Company (2021) (No's)
Figure 21 API Global Market Share, Based on Synthesis, Based on Customer Base and Biotech API Based on Product Type (2022) (%)
Figure 22 Synthetic API Global Market Share, Based on Region, (2022 V/S 2029) (%)
Figure 23 Biotech API Global Market Share, by Region, (2022 V/S 2029) (%)
Figure 24 Antibody Global Market Share, Based on Product Type (2022 vs 2029) (%)
Figure 25 Vaccines Global Market Share, Based on Region, (2022 V/S 2029) (%)
Figure 26 Biologic API Global Market Share, Based on Region, (2022 V/S 2029) (%)
Figure 27 API Global Market Share Based on Business Type, Captive API and Merchant API Based on Type (2022) (%)
Figure 28 Captive API Global Market Share, Based on Region, (2022 V/S 2029) (%)
Figure 29 Generic Merchant API Global Market Share, by Region, (2022 V/S 2029) (%)
Figure 30 API Global Market Share, Based on Application (2022 vs 2029) (%)
Figure 31 Biotech Infectious Diseases API Global Market Share, Based on Region, (2022 V/S 2029) (%)
Figure 32 Metabolic Disorder API Global Market Share, Based on Region, (2022 V/S 2029) (%)
Figure 33 Biotech Metabolic Disorders API Global Market Share, Based on Region, (2022 V/S 2029) (%)
Figure 34 Hpapi Metabolic Disorders API Global Market Share, Based on Region, (2022 V/S 2029) (%)
Figure 35 Synthetic Musculoskeletal Diseases Global Market Share, Based on Region, (2022 V/S 2029) (%)
Figure 36 API Global Market Revenue, Based Region (2021-2029) ($Mn), CAGR (%)
Figure 37 API Global Market Share, Based on Region and Based on Country (2022) (%)
Figure 38 North America API Market Revenue, by Synthesis and Biotech API Market, Based on Product Type (2022) ($ Mn)
Figure 39 North America Antibodies Market Share Based Product Type (2022 V/S 2029) (%)
Figure 40 North America Synthetic API, Biotech API and Hpapi Market Share, Based on Customer Base (2022 V/S 2029) (%)
Figure 41 North America API Market Share, by Business Type, Captive API and Merchant API Market, Based on Type (2022 V/S 2029) (%)
Figure 42 North America API Market Share, Based on Application (2022 V/S 2029) (%)
Figure 43 North America Synthetic API Market Share, Based on Application (2022 V/S 2029) (%)
Figure 44 North America Biotech API Market Share, Based on Application (2022 V/S 2029) (%)
Figure 45 North America Hpapi Market Share, Based Onapplication (2022 V/S 2029) (%)
Figure 46 North America API Market Share, Based on Country (2022 V/S 2029) (%)
Figure 47 U.S. API Market Revenue, Based on Synthesis Type, Biotech API Market Revenue, Based on Product Type and API Market, Based on Business Type (2022 V/S 2029) ($Mn)
Figure 48 U.S. API Market Revenue, Based on Application (2022 V/S 2029) ($Mn)
Figure 49 U.S. Synthetic API Market Revenue, Based on Application (2022 V/S 2029) ($Mn)
Figure 50 U.S. Biotech API Market Revenue, Based on Application (2022 V/S 2029) ($Mn)
Figure 51 U.S. Hpapi Market Revenue, Based on Application (2022 V/S 2029) ($Mn)
Figure 52 Rest of N.A. API Market Revenue, Based on Business Type, Biotech API Market Revenue, Based on Product Type and API Market, Based on Business Type (2022 V/S 2029) ($Mn)
Figure 53 Rest of N.A. API Market Revenue, Based on Application (2022 V/S 2029) ($Mn)
Figure 54 Rest of N.A. Synthetic API Market Revenue, Based on Application (2022 V/S 2029) ($Mn)
Figure 55 Rest of N.A. Biotech API Market Revenue, Based on Application (2022 V/S 2029) ($Mn)
Figure 56 Rest of N.A. Hpapi Market Revenue, Based on Application (2022 V/S 2029) ($Mn)
Figure 57 Europe API Market Revenue, Based on Synthesis and Biotech API Market, Based on Product Type (2022) ($ Mn)
Figure 58 Europr Antibodies Market Share Based Product Type (2022 V/S 2029) (%)
Figure 59 Europe Synthetic API, Biotech API and Hpapi Market Share, Based on Customer Base (2022 V/S 2029) (%)
Figure 60 Europe API Market Share Based on Business Type, Captive API and Merchant API Market, Based on Type (2022 V/S 2029) (%)
Figure 61 Europe API Market Share, Based on Application (2022 V/S 2029) (%)
Figure 62 Europe Synthetic API Market Share, Based on Application (2022 V/S 2029) (%)
Figure 63 Europe Biotech API Market Share, Based on Application (2022 V/S 2029) (%)
Figure 64 Europe Hpapi Market Share, Based on Application (2022 V/S 2029) (%)
Figure 65 Europe API Market Share, Based on Country (2022 V/S 2029) (%)
Figure 66 Italy API Market Revenue, Based on Business Type, Biotech API Market Revenue, Based on Product Type and API Market, Based on Business Type (2022 V/S 2029) ($Mn)
Figure 67 Italy API Market Revenue, Based on Application (2022 V/S 2029) ($Mn)
Figure 68 Italy Synthetic API Market Revenue, Based on Application (2022 V/S 2029) ($Mn)
Figure 69 Italy Biotech API Market Revenue, Based on Application (2022 V/S 2029) ($Mn)
Figure 70 Italy Hpapi Market Revenue, Based on Application (2022 V/S 2029) ($Mn)
Figure 71 Germany API Market Revenue, Based on Business Type, Biotech API Market Revenue, Based on Product Type and API Market, Based on Business Type (2022 V/S 2029) ($Mn)
Figure 72 Germany API Market Revenue, Based on Application (2022 V/S 2029) ($Mn)
Figure 73 Germany Synthetic API Market Revenue, Based on Application (2022 V/S 2029) ($Mn)
Figure 74 Germany Biotech API Market Revenue, Based on Application (2022 V/S 2029) ($Mn)
Figure 75 Germany Hpapi Market Revenue, Based on Application (2022 V/S 2029) ($Mn)
Figure 76 France API Market Revenue, Based on Business Type, Biotech API Market Revenue, Based on Product Type and API Market, Based on Business Type (2022 V/S 2029) ($Mn)
Figure 77 France API Market Revenue, Based on Application (2022 V/S 2029) ($Mn)
Figure 78 France Synthetic API Market Revenue, Based on Application (2022 V/S 2029) ($Mn)
Figure 79 France Biotech API Market Revenue, Based on Application (2022 V/S 2029) ($Mn)
Figure 80 France Hpapi Market Revenue, Based on Application (2022 V/S 2029) ($Mn)
Figure 81 Rest of Europe API Market Revenue, Based on Business Type, Biotech API Market Revenue, Based on Product Type and API Market, Based on Business Type (2022 V/S 2029) ($Mn)
Figure 82 Rest of Europe API Market Revenue, Based on Application (2022 V/S 2029) ($Mn)
Figure 83 Rest of Europe Synthetic API Market Revenue, Based on Application (2022 V/S 2029) ($Mn)
Figure 84 Rest of Europe Biotech API Market Revenue, Based on Application (2022 V/S 2029) ($Mn)
Figure 85 Rest of Europe Hpapi Market Revenue, Based on Application (2022 V/S 2029) ($Mn)
Figure 86 APAC API Market Revenue, Based on Synthesis and Biotech API Market, Based on Product Type (2022 V/S 2029) ($ Mn)
Figure 87 APAC Antibodies Market Share, Based on Synthesis Product Type (2022 V/S 2029) (%)
Figure 88 APAC Synthetic API, Biotech API and Hpapi Market Share, Based on Customer Base (2022 V/S 2029) (%)
Figure 89 APAC API Market Share Based on Business Type, Captive API and Merchant API Market, Based on Type (2022 V/S 2029) (%)
Figure 90 APAC API Market Share, Based on Application (2022 V/S 2029) (%)
Figure 91 APAC Synthetic API Market Share, Based on Application (2022 V/S 2029) (%)
Figure 92 APAC Biotech API Market Share, Based on Application (2022 V/S 2029) (%)
Figure 93 APAC Hpapi Market Share, Based on Application (2022 V/S 2029) (%)
Figure 94 APAC API Market Share, Based on Country (2020 V/S 2027) (%)
Figure 95 China API Market Revenue, Based on Business Type, Biotech API Market Revenue, Based on Product Type and API Market, Based on Business Type (2022 V/S 2029) ($Mn)
Figure 96 China API Market Revenue, Based on Application (2022 V/S 2029) ($Mn)
Figure 97 China Synthetic API Market Revenue, Based on Application, (2022 V/S 2029) ($Mn)
Figure 98 China Biotech API Market Revenue, Based on Application (2022 V/S 2029) ($Mn)
Figure 99 China Hpapi Market Revenue, Based on Application (2022 V/S 2029) ($Mn)
Figure 100 Japan API Market Revenue, Based on Business Type, Biotech API Market Revenue, Based on Product Type and API Market, Based on Business Type (2022 V/S 2029) ($Mn)
Figure 101 Japan API Market Revenue, Based on Application (2022 V/S 2029) ($Mn)
Figure 102 Japan Synthetic API Market Revenue, Based on Application (2022 V/S 2029) ($Mn)
Figure 103 Japan Biotech API Market Revenue, Based on Application (2022 V/S 2029) ($Mn)
Figure 104 Japan Hpapi Market Revenue, Based on Application (2022 V/S 2029) ($Mn)
Figure 105 India API Market Revenue, Based on Business Type, Biotech API Market Revenue, Based on Product Type and API Market, Based on Business Type (2022 V/S 2029) ($Mn)
Figure 106 India API Market Revenue, Based on Application (2022 V/S 2029) ($Mn)
Figure 107 India Synthetic API Market Revenue, Based on Application (2022 V/S 2029) ($Mn)
Figure 108 India Biotech API Market Revenue, Based on Application (2022 V/S 2029) ($Mn)
Figure 109 India Hpapi Market Revenue, Based on Application (2022 V/S 2029) ($Mn)
Figure 110 Rest of APAC API Market Revenue, Based on Business Type, Biotech API Market Revenue, Based on Product Type and API Market, Based Business Type (2022 V/S 2029) ($Mn)
Figure 111 Rest of APAC API Market Revenue, Based on Application (2022 V/S 2029) ($Mn)
Figure 112 Rest of APAC Synthetic API Market Revenue, Based on Application (2022 V/S 2029) ($Mn)
Figure 113 Rest of APAC Biotech API Market Revenue, Based on Application (2022 V/S 2029) ($Mn)
Figure 114 Rest of APAC Hpapi Market Revenue, Based on Application (2022 V/S 2029) ($Mn)
Figure 115 RoW API Market Revenue, Based on Synthesis and Biotech API Market, Based on Type (2022) ($ Mn)
Figure 116 RoW Antibodies Market Share, Based on Product Type (2022 vs 2029) (%)
Figure 117 RoW Synthetic API, Biotech API and Hpapi Market Share, Based on Customer Base (2022 V/S 2029) (%)
Figure 118 RoW API Market Share, Based on Business Type, Captive API and Merchant API Market, Based on Type (2022 V/S 2029) (%)
Figure 119 RoW API Market Share, Based on Application (2022 V/S 2029) (%)
Figure 120 RoW Synthetic API Market Share, Based on Application (2022 V/S 2029) (%)
Figure 121 RoW Biotech API Market Share, Based on Application (2022 V/S 2029) (%)
Figure 122 RoW Hpapi Market Share, Based on Application (2022 V/S 2029) (%)
Figure 123 RoW API Share, Based on Country (2022 V/S 2029) (%)
Figure 124 Brazil API Market Revenue, Based on Business Type, Biotech API Market Revenue, Based on Product Type and API Market, Based on Business Type (2022 V/S 2029) ($Mn)
Figure 125 Brazil API Market Revenue, Based on Application (2022 V/S 2029) ($Mn)
Figure 126 Brazil Synthetic API Market Revenue, Based on Application (2022 V/S 2029) ($Mn)
Figure 127 Brazil Biotech API Market Revenue, Based on Application (2022 V/S 2029) ($Mn)
Figure 128 Brazil Hpapi Market Revenue, Based on Application (2022 V/S 2029) ($Mn)
Figure 129 Rest of Latam API Market Revenue, Based on Business Type, Biotech API Market Revenue, Based on Product Type and API Market, Based on Business Type (2022 V/S 2029) ($Mn)
Figure 130 Rest of Latam API Market Revenue, Based on Application (2022 V/S 2029) ($Mn)
Figure 131 Rest of Latam Synthetic API Market Revenue, Based on Application (2022 V/S 2029) ($Mn)
Figure 132 Rest of Latam Biotech API Market Revenue, Based on Application (2022 V/S 2029) ($Mn)
Figure 133 Rest of Latam Hpapi Market Revenue, Based on Application (2022 V/S 2029) ($Mn)
Figure 134 Middle East & Others API Market Revenue, Based on Business Type, Biotech API Market Revenue, Based on Product Type and API Market, Based on Business Type (2022 V/S 2029) ($Mn)
Figure 135 Middle East & Others API Market Revenue, Based on Application (2022 V/S 2029) ($Mn)
Figure 136 Middle East & Others Synthetic API Market Revenue, Based on Application (2022 V/S 2029) ($Mn)
Figure 137 Middle East & Others Biotech API Market Revenue, Based on Application (2022 V/S 2029) ($Mn)
Figure 138 Middle East & Others Hpapi Market Revenue, Based on Application (2022 V/S 2029) ($Mn)
Figure 139 Key Growth Strategies, (2020-2022)
Figure 140 SWOT: Catalent Inc.
Figure 141 SWOT: Divis Laboratories
Figure 142 SWOT: Euroapi
Figure 143 SWOT: Lonza Group
Figure 144 SWOT: Pfizer Inc.
Figure 145 SWOT: Samsung Biologics
Figure 146 SWOT: Teva Pharmaceutical Industries Limited
Figure 147 SWOT: Thermo Fisher Scientific
Figure 148 SWOT: Wuxi Apptech
Figure 149 SWOT: Wuxi Biologics
Samples
LOADING...
Companies Mentioned
- Aarti Drugs Ltd
- AbbVie Inc.
- ACIC Pharmaceuticals Inc.
- Adimmune Corporation
- Ajinomoto Bio-Pharma Services
- Albemarle Corporation
- Alembic Ltd
- Alkem laboratories Ltd.
- Almac Group
- Alven Laboratories S.r.o.
- Ambio Pharma Inc.
- Amneal Pharmaceuticals Inc.
- Apicore LLC
- Aragen Life Sciences (GVK Biosciences Private Limited)
- Arene Lifesciences Limited.
- AstraZeneca plc
- Aurobindo Pharma
- Ampac fine chemicals LLC
- Axplora
- BASF SE
- Bayer AG
- Bachem holding AG
- Bal Pharma Ltd.
- Biocon Limited
- Biogen Inc.
- Biomarin Pharmaceutical Inc
- Biophore India Pharmaceuticals Pvt. Ltd.
- Biosortia Pharmaceuticals Inc.
- Biotechnica Pharma Global
- Blanver
- Boehringer Ingelheim GmbH
- Brawn Biotech Ltd.
- Bristol-Myers Squibb Company
- Cadila Pharmaceuticals Limited
- Curia
- Catalent, Inc.
- Cayman Chemicals
- Celltrion Inc.,
- Cambrex Corporation
- Century Pharmaceuticals Ltd
- CFM Group (AMSA S.P.A)
- Changzhou Pharmaceutical Factory
- ChemCon GmbH
- China Chemical & Pharmaceutical Co., Ltd.
- Chongqing Huapont Pharmaceutical CO LTD,
- Cipla Limited
- CKD Bio
- Corden Pharma International (Germany)
- CSL Ltd
- Daiichi Sankyo Chemical Pharma Co Ltd
- Daito Pharmaceutical Co., Ltd
- Dishman Carbogen Amcis
- Dr.Reddy’s Laboratories
- Eisai Co., Ltd.
- Eli Lilly and Company
- Emcure Pharmaceuticals Ltd.
- Ercros S.A.
- Estechpharma Co., Ltd.
- Esteve Química SA
- Everest Organics Limited
- Evonik Industries AG
- F. Hoffmann-La Roche AG
- Fareva Group
- FIS Fabbrica Italiana Sintetici SPA
- Flamma S.p.A
- Formosa Laboratories, Inc.
- Fuji Chemical Industry Co.,Ltd
- Gentec Pharmaceutical Group S.A (DUKE CHEM and PHARMANOID)
- Gilead Sciences, Inc.
- Givaudan (Indena)
- Gland Pharma Limited
- GlaxoSmithKline plc
- Glenmark Pharmaceutical Ltd.
- GRANULES INDIA LTD.
- Grupo Ferrer Internacional S.A (Interquim, S.A)
- Harman Finochem Limited.
- Heraeus Holding GmbH
- Hetero Labs Ltd.
- Hikma pharmaceuticals
- Hybio Pharmaceutical Co., Ltd.
- Hikal Ltd.
- Ibio Inc
- Inabata Co. Ltd.
- INTAS PHARMACEUTICALS LTD,
- Jeil Pharmaceutical Co. Ltd.,
- Johnson and Johnson
- Johnson Matthey Pharma Services Inc.
- Jubilant lifesciences (Jubilant generics Ltd)
- Katsura Chemical Co.,Ltd.
- Kern Pharma, S.L.,
- Kleos pharma
- Koçak Farma Pharmaceutical
- Kosher Pharmaceuticals
- Krka, tovarna zdravil, d. d., Novo mesto
- Kyowa Hakko Kirin
- Laboratorium ofichem bv
- Lannett Company Inc.
- Laurus Labs
- Lebsa
- Lonza group
- Lusochimica S.p.A
- LOTUS Pharmaceutical Co., Ltd.
- Lesaffre (Gnosis S.p.A.)
- Magle Chemoswed AB
- Mallinckrodt Pharmaceuticals
- Medichem S.A
- Megafine Pharma Ltd
- Mehta API
- Merck KGaA
- Metrochem API
- Micro Labs LTD
- Minakem High Potent S.A.
- Moehs Iberica SL
- Molcan
- Morepen
- MSN Organics Pvt, Ltd.
- Natco Pharma
- Neuland laboratories Ltd.
- Novartis International AG
- Novo Holdings A/S
- Olainfarm JSC
- OLON S.P.A.
- Orchid Chemicals & Pharmaceuticals Ltd
- Orion (Fermion)
- Optimus Drugs Private LTD.
- Paratek Pharmaceuticals, Inc.
- Perrigo Company plc,
- Pfizer Inc.
- Phyton Biotech LLC
- Pierre Fabre
- Polpharma
- Prajna Generics Pvt. Ltd.
- Protex International (ICROM S.p.A.)
- Rablon Healthcare Pvt Ltd
- Saneca Pharmaceuticals a.s.
- Sanofi S.A.
- Solara Active Pharma
- Seikagaku Corporation
- SEQUENS (Wavelength Pharmaceuticals)
- Shiono Chemical Co., Ltd.
- SM BIOMED SDN. BHD
- Siegfried Holding AG
- Standard Chemical & Pharmaceutical Co.
- Sumitomo Dainippon Pharma Co., Ltd.
- Sun Pharmaceutical Industries Ltd
- Syn-tech chem. And Pharma.Co., Ltd
- Takeda Pharmaceutical Company Limited
- Temad Co.
- Teva Pharmaceutical industries Ltd.
- Umicore
- Unichem Laboratories LTD.
- Union Quimico Farmaceutica, S.A. UQUIFA,
- Venus Remedies Limited
- Vertex Pharmaceuticals Inc.
